330 related articles for article (PubMed ID: 28026153)
1. Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.
Wang L; Zhao QH; Pudasaini B; Jiang R; Gong SG; He J; Yuan P; Liu JM
Clin Respir J; 2018 Mar; 12(3):915-921. PubMed ID: 28026153
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vascular response patterns during exercise in interstitial lung disease.
Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
Awerbach JD; Stackhouse KA; Lee J; Dahhan T; Parikh KS; Krasuski RA
Respir Med; 2019 Apr; 150():126-130. PubMed ID: 30961938
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.
Zimmermann GS; von Wulffen W; Huppmann P; Meis T; Ihle F; Geiseler J; Leuchte HH; Tufman A; Behr J; Neurohr C
Respirology; 2014 Jul; 19(5):700-6. PubMed ID: 24697923
[TBL] [Abstract][Full Text] [Related]
6. Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
Nemoto K; Oh-Ishi S; Akiyama T; Yabuuchi Y; Goto H; Nonaka M; Sasatani Y; Tachi H; Arai N; Ishikawa H; Hyodo K; Hase I; Miura Y; Takaku T; Hayashihara K; Saito T
BMC Pulm Med; 2019 Sep; 19(1):167. PubMed ID: 31477076
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
Andersen CU; Mellemkjær S; Hilberg O; Nielsen-Kudsk JE; Simonsen U; Bendstrup E
Respir Med; 2012 Jun; 106(6):875-82. PubMed ID: 22425136
[TBL] [Abstract][Full Text] [Related]
8. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
Fischer A; Swigris JJ; Bolster MB; Chung L; Csuka ME; Domsic R; Frech T; Hinchcliff M; Hsu V; Hummers LK; Gomberg-Maitland M; Mathai SC; Simms R; Steen VD
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-109-14. PubMed ID: 25372796
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.
Nowak J; Hudzik B; Jastrzȩbski D; Niedziela JT; Rozentryt P; Wojarski J; Ochman M; Karolak W; Żegleń S; Gierlotka M; Gąsior M
Clin Respir J; 2018 Mar; 12(3):930-938. PubMed ID: 28052583
[TBL] [Abstract][Full Text] [Related]
14. Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.
Teramachi R; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Yokoyama T; Furukawa T; Yagi M; Sakamoto K; Hashimoto N; Hasegawa Y
Respir Investig; 2021 May; 59(3):342-349. PubMed ID: 33579646
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
16. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
17. Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.
Kamide H; Kato S; Hayakawa K; Fukui K; Kitamura H; Ogura T; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
Int J Cardiovasc Imaging; 2021 Mar; 37(3):1073-1083. PubMed ID: 33113068
[TBL] [Abstract][Full Text] [Related]
18. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.
Oliveira RKF; Waxman AB; Hoover PJ; Dellaripa PF; Systrom DM
Chest; 2020 Jul; 158(1):350-358. PubMed ID: 32173491
[TBL] [Abstract][Full Text] [Related]
20. Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
Sobiecka M; Lewandowska K; Kober J; Franczuk M; Skoczylas A; Tomkowski W; Kuś J; Szturmowicz M
Lung; 2020 Jun; 198(3):547-554. PubMed ID: 32206858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
